Dr. Jai Radhakrishnan, MD

Dr. Radhakrishnan practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Radhakrishnan's NPI, 1275605446, was assigned on November 14, 2006. Dr. Radhakrishnan graduated from Jawaharlal Institute of Postgraduate Medical Education and Research in 1984. Dr. Radhakrishnan holds New York license 197476.

Dr. Radhakrishnan's primary practice is Trustees of Columbia University in the City of New York, at 51 Audubon Ave, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Radhakrishnan's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Radhakrishnan is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Radhakrishnan to 1 more dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Radhakrishnan practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Radhakrishnan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Radhakrishnan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Radhakrishnan's licenses on file in 4 states: New York, Florida, New Jersey and Connecticut.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts, kidney disease and parathyroid gland disorder among the conditions Dr. Radhakrishnan treats.

CMS data shows 1,128 Medicare services from Dr. Radhakrishnan across 9 procedure codes in 2024, for 293 Medicare patients. Medicare paid $114,699 for them.

CMS counts 293 Medicare patients who saw Dr. Radhakrishnan in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Radhakrishnan's median patient age at 60, with 45% women.

In 2024, Dr. Radhakrishnan wrote 286 Medicare Part D claims for 72 patients. 81% of them were for generic drugs. CMS names the drug for 98 of them, across 6 drugs with 11 or more claims each, at $46,621 in total drug cost. In 2023, CMS named 138 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Radhakrishnan for performance year 2024, reported through an alternative payment model (APM). Dr. Radhakrishnan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Radhakrishnan as offering telehealth.

Dmand AI links 186 papers to Dr. Radhakrishnan, published from 2006 to 2025. 2023 was the busiest year, with 14. The most frequent topics are Kidney, Immunosuppressive Agents and Kidney Failure, Chronic. Dr. Radhakrishnan has published most often in Kidney Int. Dr. Radhakrishnan's most frequent co-authors are Gerald Bernard Appel, MD, Sumit Mohan, MD and Andrew S. Bomback, MD.

Dmand AI links Dr. Radhakrishnan to 4 clinical trials. Conditions studied include Diabetic Nephropathies, Glomerulonephritis, Membranous and Nephrotic Syndrome. Open Payments lists research payments to Dr. Radhakrishnan that name 1 trial.

CMS Open Payments shows 228 general payments to Dr. Radhakrishnan from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Amgen Inc. paid the most, $75,134. It also lists 10 research payments totaling $33,969 from 2016 to 2024, naming 1 clinical trial.

Dmand AI lists 23 awards for Dr. Radhakrishnan, most recently Best Morning Report Attending in 2014.

Dr. Radhakrishnan graduated from Jawaharlal Institute of Postgraduate Medical Education and Research in 1984. Dr. Radhakrishnan is a member of ASN and ISN.

Dr. Radhakrishnan is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.